- Trials with a EudraCT protocol (261)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
261 result(s) found for: cardiac surgical procedures.
Displaying page 3 of 14.
EudraCT Number: 2016-003902-14 | Sponsor Protocol Number: 16-118 | Start Date*: 2017-07-06 |
Sponsor Name:RWTH Aachen University, represented by the Clinical Trial Center (CTC-A) | ||
Full Title: Intravenous Fish Oil based Lipid Emulsion as Pharmaconutrient Strategy in High-Risk Cardiac Surgery Patients: a Phase II Dosing Study | ||
Medical condition: Given the recently meta-analyzed data from previous RCTs about fish oil , we hypothesize that the provision of intravenous (i.v.) FO (0.20 g/kg and 0.50 g/kg) to cardiac surgery patients may reduc... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001033-24 | Sponsor Protocol Number: 1234 | Start Date*: 2016-01-25 | |||||||||||
Sponsor Name:AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO | |||||||||||||
Full Title: The management of post-operative pain nia patients undergoing cardiac surgery mini - invasive minithoracotomy : Randomized trial | |||||||||||||
Medical condition: The management of postoperative pain in patients undergoing cardiac surgery minimally invasive minithoracotomy : randomized | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004295-28 | Sponsor Protocol Number: STER-AMVR-01 | Start Date*: 2014-11-14 | |||||||||||
Sponsor Name:Oulu University Hospital, Department of Anaesthesia | |||||||||||||
Full Title: Postoperative pain management after heart valve surgery using parasternal block and PCA Oxycodone | |||||||||||||
Medical condition: Mitral or aortic valve disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001795-34 | Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20 | Start Date*: 2023-01-30 | |||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||
Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children | |||||||||||||
Medical condition: Preservation of hearts prior to heart transplantation in children | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005440-98 | Sponsor Protocol Number: | Start Date*: 2012-04-12 | |||||||||||
Sponsor Name:AKH Linz | |||||||||||||
Full Title: Double blinded randomised trial for the evaluation of the effectiveness of prophylactic use of sildenafil for the prevention of pulmonary hypertensive crisis after congenital heart surgery | |||||||||||||
Medical condition: Ventriculs septal defect, atrioventricular canal with pulmonary hypertension | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003036-12 | Sponsor Protocol Number: IFX-1-P2.2 | Start Date*: 2016-04-22 | ||||||||||||||||
Sponsor Name:InflaRx GmbH | ||||||||||||||||||
Full Title: A phase II randomized, placebo-controlled, double-blind, dose-escalation study to evaluate safety, pharmacokinetics and pharmacodynamic dose response relationship of IFX-1 in patients undergoing co... | ||||||||||||||||||
Medical condition: Prevention of organ dysfunction induced by inflammatory response after complex cardiac surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003498-13 | Sponsor Protocol Number: HIP/FUSION#1 | Start Date*: 2016-03-18 | |||||||||||
Sponsor Name:Institut for Klinisk Medicin, Aarhus Universitet | |||||||||||||
Full Title: Surgical anesthesia for elective hip surgery - hemodynamic effect of lumbosacral plexus blockade compared to continuous spinal anesthesia | |||||||||||||
Medical condition: No specific medical condition is investigated. The objective of the investigation is to compare two methods for surgical anesthesia for total hip replacement. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002671-14 | Sponsor Protocol Number: CRAD001ADE14 | Start Date*: 2008-02-18 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A 15-month, multi-center, randomized, open-label, parallel group study investigating the renal tolerability, efficacy and safety of a CNI-free regimen (Certican® and MPA) versus a low-dose CNI- reg... | |||||||||||||
Medical condition: heart transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000401-76 | Sponsor Protocol Number: 7715 | Start Date*: 2019-11-26 |
Sponsor Name:University hospital of Montpellier | ||
Full Title: Transfusion savings in heart surgery: impact of individual strategy, optimized by erythropoietin (EPO) and metabolic adjustment (ScvO2) | ||
Medical condition: Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005136-76 | Sponsor Protocol Number: ASINC101C | Start Date*: 2005-05-02 |
Sponsor Name:Professor Christina Eintrei,Institution of Medical & Health, Section of Anesthesiology | ||
Full Title: Aspirin in noncardiac surgery | ||
Medical condition: Patients with cardiovascular risk factors undergoing elective non-cardiac surgery of high or intermediate risk. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004399-68 | Sponsor Protocol Number: 1925-201-008 | Start Date*: 2019-03-29 | |||||||||||
Sponsor Name:Allergan Ltd. | |||||||||||||
Full Title: A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A (AGN 151607) Injections into the Epicardial F... | |||||||||||||
Medical condition: Post-operative atrial fibrillation (POAF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) ES (Completed) AT (Completed) SE (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017595-25 | Sponsor Protocol Number: 04-AnIt-09/UKM09_0031 | Start Date*: 2011-02-22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University Hospital Muenster | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Balanced 6 % HES 130/0.4 vs. balanced crystalloid-based infusion in patients undergoing colorectal surgery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients undergoing colorectal surgery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003648-31 | Sponsor Protocol Number: PKPDHM-001 | Start Date*: 2011-11-17 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: Pharmacokinetic-pharmacodynamic modeling of the postoperative pain sensation during patient-controlled analgesia with target-controlled infusion of Hydromorphone, taking into account the interactio... | |||||||||||||
Medical condition: Pain therapy after elective cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003714-68 | Sponsor Protocol Number: 1744/2017 | Start Date*: 2017-11-15 | ||||||||||||||||
Sponsor Name:Medical University of Vienna | ||||||||||||||||||
Full Title: Effect of Supplemental Oxygen on Perioperative Brain Natriuretic Peptide Concentration in Cardiac Risk Patients - A prospective randomized clinical trial | ||||||||||||||||||
Medical condition: Evaluation of the effect of 80% versus 30% supplemental oxygen administration during major abdominal surgery on postoperative brain natriuretic peptide concentration. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-002126-90 | Sponsor Protocol Number: 2019/399/HP | Start Date*: 2021-03-09 | ||||||||||||||||
Sponsor Name:Direction de la Recherche Clinique et de l’Innovation – CHU de Rouen | ||||||||||||||||||
Full Title: Opioid-Free Anesthesia in Cardiac Surgery | ||||||||||||||||||
Medical condition: Patients undergoing cardiac surgery under extracorporeal circulation with at least one aorto-coronary bypass and the removal of at least one internal mammary artery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004657-89 | Sponsor Protocol Number: BIOS-16-001 | Start Date*: 2020-12-14 |
Sponsor Name:Ethicon Inc | ||
Full Title: A Prospective Study Evaluating the Safety and Effectiveness of EVARREST® Fibrin Sealant Patch in Controlling Mild or Moderate Hepatic Parenchyma or Soft Tissue Bleeding During Open, Abdominal, Retr... | ||
Medical condition: Mild or moderate hepatic parenchyma or soft tissue bleeding during open, abdominal, retroperitoneal, pelvic and thoracic (non-cardiac) surgery | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000187-15 | Sponsor Protocol Number: MK-8616-145 | Start Date*: 2017-09-18 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 4 Randomized, Active-Comparator Controlled Clinical Trial to Study the Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or Vecu... | |||||||||||||
Medical condition: Reversal of neuromuscular blockade | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002606-39 | Sponsor Protocol Number: 20162020 | Start Date*: 2016-11-09 | |||||||||||
Sponsor Name:Nemocnice Na Homolce | |||||||||||||
Full Title: Resurgence in sternotomy fortified by vitamin D supplementation in cardiac surgery | |||||||||||||
Medical condition: sternotomy healing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002248-26 | Sponsor Protocol Number: IEOS701/412 | Start Date*: 2012-10-16 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: Prevention of anthracycline-induced cardiotoxicity: a multicentre randomizedtrial comparing two therapeutic strategies. | |||||||||||||
Medical condition: Anthracycline-‐induced cardiotoxicity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004446-42 | Sponsor Protocol Number: MB11-2018 | Start Date*: 2019-06-20 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S.CROCE E CARLE CUNEO | |||||||||||||
Full Title: Maintenance Of aNtiplatElet Therapy in patients with coronary stenting undergoing surgery | |||||||||||||
Medical condition: Patients a least 18 years of age on DAPT per standard of care who are planned to undergo non deferrable cardiac and non cardiac surgery which will require discontinuation of a P2Y12 inhibitor. Subj... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
